Notice ID: 52d1a274ef7e459c8a725f14f01a5048Combined Synopsis/SolicitationArchived
Evaluating the utility of bulk RNA transcriptomics
Archived on July 17, 2025. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 3:00 PM EDT
- Posted
- July 10, 2025
- Notice type
- Combined Synopsis/Solicitation
- Set-aside
- No Set aside used
- NAICS
- 541714: Research and Development in Biotechnology (except Nanobiotechnology)
- Agency
- Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION
Notice details
- Office
- FDA OFFICE OF ACQ GRANT SVCS
- Place of performance
- Silver Spring, 20993
- PSC
- AJ12: R&D- GENERAL SCIENCE/TECHNOLOGY: PHYSICAL SCIENCES (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Last updated
- Nov 11, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- FDA-CDER-25-128751
- Notice ID
- 52d1a274ef7e459c8a725f14f01a5048
Description
The objective of this contract is to obtain service required to complete bulk transcriptomics of RNAs from treated and untreated primary liver hepatocytes. Transcriptomics data generated from bulk RNA sequencing will identify changes occurring for both coding and noncoding RNAs in primary human hepatocytes (PHHs) following treatment. Obtain the service required to complete bulk RNA sequencing or transcriptomics from treated primary liver hepatocytes (PHHS). Transcriptomics data generated from bulk RNA sequencing will quantify expression of both coding and noncoding RNAs in PHHs.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Documents
Files (5)
- Download
Contractor Questions and Answers FDA-CDER-25-128751_07102025.pdf
127 KBAdded in Combined Synopsis/Solicitation version 4Posted - Download
Contractor Questions and Answers FDA-CDER-25-128751.pdf
66 KBAdded in Combined Synopsis/Solicitation version 2Posted - Download
Other_Attachment No. 2 - HHS Class Deviation.pdf
107 KBAdded in Combined Synopsis/Solicitation version 1Posted - Download
Other_Attachment No. 1 - FAR Class Deviation.pdf
316 KBAdded in Combined Synopsis/Solicitation version 1Posted - Download
RFQ CDER-25-128751 Genomic Services .pdf
456 KBAdded in Combined Synopsis/Solicitation version 1Posted
Lifecycle
- 1Version 1Combined Synopsis/SolicitationArchived
Evaluating the utility of bulk RNA transcriptomics
- 2Version 2Combined Synopsis/SolicitationArchived
Evaluating the utility of bulk RNA transcriptomics
- 4Version 4Combined Synopsis/SolicitationArchivedCurrent
Evaluating the utility of bulk RNA transcriptomics
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
FDA-CDER-25-128751
Archive Date
Jul 17, 2025